Possible association between TGF-β1 polymorphism and oral cancer

International Journal of Immunogenetics

Volumn 40, Issue 4, 2013, Pages 292-298

  Carneiro, N K ^a   Oda, J M M ^a   Losi Guembarovski, R ^a   Ramos, G ^b   Oliveira, B V ^b   Cavalli, I J ^c   De S F Ribeiro, E M ^c   Goncalves M S B ^a   Watanabe, M A E ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b Hospital Erasto Gaertner   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; TRANSFORMING GROWTH FACTOR BETA1; GENETIC MARKER; SIGNAL PEPTIDE;

ADULT; ALLELE; ARTICLE; BLOOD ANALYSIS; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME; DNA SEQUENCE; GENE FREQUENCY; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; MOUTH TUMOR; NUCLEOTIDE SEQUENCE; SMOKING; SQUAMOUS CELL CARCINOMA;

ADULT; ALLELES; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN SORTING SIGNALS; SEQUENCE ANALYSIS, DNA; SMOKING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84880121718     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/iji.12037     Document Type: Article

References (62)

1. Akhurst, R.J. & Derynck, R. (2001) Tgf-beta signaling in cancer-a double-edged sword. Trends in Cell Biology, 11, S44.
2. Awad, M.R., El-Gamel, A., Hasleton, P., Turner, D.M., Sinnott, P.J. & Hutchinson, I.V. (1998) Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation, 66, 1014.
3. Berndt, S.I., Huang, W.Y., Chatterjee, N., Yeager, M., Welch, R., Chanock, S.J., Weissfeld, J.L., Schoen, R.E. & Hayes, R.B. (2007) Transforming growth factor beta 1 (tgfb1) gene polymorphisms and risk of advanced colorectal adenoma. Carcinogenesis, 28, 1965.
4. Beyer, M., Kochanek, M., Giese, T., Endl, E., Weihrauch, M.R., Knolle, P.A., Classen, S. & Schultze, J.L. (2006) In vivo peripheral expansion of naive cd4+cd25high foxp3+ regulatory t cells in patients with multiple myeloma. Blood, 107, 3940.
5. Bierie, B. & Moses, H.L. (2009) Gain or loss of tgfbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle, 8, 3319.
6. Cambien, F., Ricard, S., Troesch, A., Mallet, C., Generenaz, L., Evans, A., Arveiler, D., Luc, G., Ruidavets, J.B. & Poirier, O. (1996) Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The etude cas-temoin de l'infarctus du myocarde (ectim) study. Hypertension, 28, 881.
7. Chang, S.J., Chen, C.J., Tsai, F.C., Lai, H.M., Tsai, P.C., Tsai, M.H. & Ko, Y.C. (2008) Associations between gout tophus and polymorphisms 869t/c and -509c/t in transforming growth factor beta1 gene. Rheumatology (Oxford), 47, 617.
8. Chen, T., Yan, W., Wells, R.G., Rimm, D.L., McNiff, J., Leffell, D. & Reiss, M. (2001) Novel inactivating mutations of transforming growth factor-beta type i receptor gene in head-and-neck cancer metastases. International Journal of Cancer, 93, 653.
9. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N., McGrady, G. & Wahl, S.M. (2003) Conversion of peripheral cd4+cd25- naive t cells to cd4+cd25+ regulatory t cells by tgf-beta induction of transcription factor foxp3. Journal of Experimental Medicine, 198, 1875.
10. Colakogullari, M., Ulukaya, E., Yilmaztepe Oral, A., Aymak, F., Basturk, B., Ursavas, A. & Oral, H.B. (2008) The involvement of il-10, il-6, ifn-gamma, tnf-alpha and tgf-beta gene polymorphisms among turkish lung cancer patients. Cell Biochemistry and Function, 26, 283.
11. De Ruyck, K., Van Eijkeren, M., Claes, K., Bacher, K., Vral, A., De Neve, W. & Thierens, H. (2006) Tgfβ1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors. International Journal of Radiation Oncology, Biology, Physics, 65, 1240.
12. Derynck, R. & Zhang, Y.E. (2003) Smad-dependent and smad-independent pathways in tgf-beta family signalling. Nature, 425, 577.
13. Dunn, G.P., Old, L.J. & Schreiber, R.D. (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 21, 137.
14. Dunning, A.M., Ellis, P.D., McBride, S., Kirschenlohr, H.L., Healey, C.S., Kemp, P.R. et al. (2003) A transforming growth factorβ1 signal peptide variant increases secretion in vitro and is associated with increased incidence of invasive breast cancer. Cancer Research, 63, 2610.
15. Elliott, R.L. & Blobe, G.C. (2005) Role of transforming growth factor beta in human cancer. Journal of Clinical Oncology, 23, 2078.
16. Ewart-Toland, A., Chan, J.M., Yuan, J., Balmain, A. & Ma, J. (2004) A gain of function tgfb1 polymorphism may be associated with late stage prostate cancer. Cancer Epidemiology Biomarkers & Prevention, 13, 759.
17. Fang, F., Yu, L., Zhong, Y. & Yao, L. (2010) Tgfb1 509 c/t polymorphism and colorectal cancer risk: a meta-analysis. Medical Oncology, 27, 1324.
18. Fujita, T., Teramoto, K., Ozaki, Y., Hanaoka, J., Tezuka, N., Itoh, Y. et al. (2009) Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types. Cancer Research, 69, 5142.
19. Gonzalez-Zuloeta Ladd, A.M., Arias-Vasquez, A., Siemes, C., Coebergh, J.W., Hofman, A., Witteman, J., Uitterlinden, A., Stricker, B.H. & van Duijn, C.M. (2007) Transforming-growth factor beta1 leu10pro polymorphism and breast cancer morbidity. European Journal of Cancer, 43, 371.
20. Grainger, D.J., Heathcote, K., Chiano, M., Snieder, H., Kemp, P.R., Metcalfe, J.C., Carter, N.D. & Spector, T.D. (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Human Molecular Genetics, 8, 93.
21. Gu, D., Zhuang, L., Huang, H., Cao, P., Wang, D., Tang, J. & Chen, J. (2010) Tgfb1 t29c polymorphism and breast cancer risk: a meta-analysis based on 10 417 cases and 11 455 controls. Breast Cancer Research and Treatment, 123, 857.
22. Guan, X., Sturgis, E.M., Lei, D., Liu, Z., Dahlstrom, K.R., Wei, Q. & Li, G. (2010) Association of tgf-beta1 genetic variants with hpv16-positive oropharyngeal cancer. Clinical Cancer Research, 16, 1416.
23. Hishida, A., Iwata, H., Hamajima, N., Matsuo, K., Mizutani, M., Iwase, T. et al. (2003) Transforming growth factor b1 t29c polymorphism and breast cancer risk in Japanese women. Breast Cancer, 10, 63.
24. Iamaroon, A., Pattamapun, K. & Piboonniyom, S.O. (2006) Aberrant expression of smad4, a tgf-beta signaling molecule, in oral squamous cell carcinoma. Journal of Oral Science, 48, 105.
25. Jin, G., Deng, Y., Miao, R., Hu, Z., Zhou, Y., Tan, Y. et al. (2008) Tgfb1 and tgfbr2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a chinese population. Journal of Cancer Research and Clinical Oncology, 134, 345.
26. Kaklamani, V.G., Baddi, L., Liu, J., Rosman, D., Phukan, S., Bradley, C. et al. (2005) Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk. Cancer Research, 65, 3454.
27. Kang, H.G., Chae, M.H., Park, J.M., Kim, E.J., Park, J.H., Kam, S. et al. (2006) Polymorphisms in tgf-beta1 gene and the risk of lung cancer. Lung Cancer, 52, 1.
28. Kim, M.M. & Califano, J.A. (2004) Molecular pathology of head-and-neck cancer. International Journal of Cancer, 112, 545.
29. Kirby, L.T. (1990) DNA Fingerprinting: An introduction. Stockton Press, New York.
30. Kirshner, J., Jobling, M.F., Pajares, M.J., Ravani, S.A., Glick, A.B., Lavin, M.J., Koslov, S., Shiloh, Y. & Barcellos-Hoff, M.H. (2006) Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress. Cancer Research, 66, 10861.
31. Lee, K.M., Park, S.K., Hamajima, N., Tajima, K., Yoo, K.Y., Shin, A. et al. (2005) Genetic polymorphisms of tgf-beta1 & tnf-beta and breast cancer risk. Breast Cancer Research and Treatment, 90, 149.
32. Li, M.O. & Flavell, R.A. (2008) Tgf-beta: a master of all t cell trades. Cell, 134, 392.
33. Li, Z., Habuchi, T., Tsuchiya, N., Mitsumori, K., Wang, L., Ohyama, C. et al. (2004) Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10. Carcinogenesis, 25, 237.
34. Li, M.O., Wan, Y.Y., Sanjabi, S., Robertson, A.K. & Flavell, R.A. (2006) Transforming growth factor-beta regulation of immune responses. Annual Review of Immunology, 24, 99.
35. Li, T., Cao, B.W., Dai, Y., Cui, H., Yang, H.L. & Xu, C.Q. (2008) Correlation of transforming growth factor beta-1 gene polymorphisms c-509t and t869c and the risk of gastric cancer in china. Journal of Gastroenterology and Hepatology, 23, 638.
36. Lu, S.L., Reh, D., Li, A.G., Woods, J., Corless, C.L., Kulesz-Martin, M. & Wang, X.J. (2004) Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Research, 64, 4405.
37. Mao, L., Hong, W.K. & Papadimitrakopoulou, V.A. (2004) Focus on head and neck cancer. Cancer Cell, 5, 311.
38. Massague, J. (2008) Tgfbeta in cancer. Cell, 134, 215.
39. Mazur, G., Bogunia-Kubik, K., Wrobel, T., Kuliczkowski, K. & Lange, A. (2006) Tgf-beta1 gene polymorphisms influence the course of the disease in non-hodgkin's lymphoma patients. Cytokine, 33, 145.
40. Meyer, A., Dork, T., Bogdanova, N., Brinkhaus, M.J., Wiese, B., Hagemann, J. et al. (2009) Tgfb1 gene polymorphism leu10pro (c.29t>c), prostate cancer incidence and quality of life in patients treated with brachytherapy. World Journal of Urology, 27, 371.
41. Migita, K., Miyazoe, S., Maeda, Y., Daikoku, M., Abiru, S., Ueki, T. et al. (2005) Cytokine gene polymorphisms in japanese patients with hepatitis b virus infection-association between tgf-beta1 polymorphisms and hepatocellular carcinoma. Journal of Hepatology, 42, 505.
42. Minamiya, Y., Miura, M., Hinai, Y., Saito, H., Ito, M., Ono, T., Toda, H., Motoyama, S. & Ogawa, J. (2010) Transforming growth factor-beta1 29t>c genetic polymorphism is associated with lymph node metastasis in patients with adenocarcinoma of the lung. Tumour Biology, 31, 437.
43. Mincione, G., Di Marcantonio, M.C., Artese, L., Vianale, G., Piccirelli, A., Piccirilli, M. et al. (2008) Loss of expression of tgf-beta1, tbetari, and tbetarii correlates with differentiation in human oral squamous cell carcinomas. International Journal of Oncology, 32, 323.
44. Muro-Cacho, C.A., Rosario-Ortiz, K., Livingston, S. & Munoz-Antonia, T. (2001) Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated smad2. Clinical Cancer Research, 7, 1618.
45. Pardali, K. & Moustakas, A. (2007) Actions of tgf-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochimica et Biophysica Acta, 1775, 21.
46. Qiu, W., Schonleben, F., Li, X. & Su, G.H. (2007) Disruption of transforming growth factor beta-smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of smad2 and smad4. Cancer Letters, 245, 163.
47. Shin, A., Shu, X.O., Cai, Q., Gao, Y.T. & Zheng, W. (2005) Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages. Cancer Epidemiology, Biomarkers & Prevention, 14, 1567.
48. Siegel, P.M. & Massague, J. (2003) Cytostatic and apoptotic actions of tgf-beta in homeostasis and cancer. Nature Reviews Cancer, 3, 807.
49. Sparks, R., Bigler, J., Sibert, J.G., Potter, J.D., Yasui, Y. & Ulrich, C.M. (2004) Tgfbeta1 polymorphism (l10p) and risk of colorectal adenomatous and hyperplastic polyps. International Journal of Epidemiology, 33, 955.
50. Suthanthiran, M., Li, B., Song, J.O., Ding, R., Sharma, V.K., Schwartz, J.E. & August, P. (2000) Transforming growth factor-beta 1 hyperexpression in african-american hypertensives: a novel mediator of hypertension and/or target organ damage. Proceedings of the National Academy of Sciences of the United States of America, 97, 3479.
51. Teixeira, A.L., Araujo, A., Coelho, A., Ribeiro, R., Gomes, M., Pereira, C. & Medeiros, R. (2011) Influence of tgfb1+869t>c functional polymorphism in non-small cell lung cancer (nsclc) risk. Journal of Cancer Research and Clinical Oncology, 137, 435.
52. Wang, H.Y. & Wang, R.F. (2007) Regulatory t cells and cancer. Current Opinion in Immunology, 19, 217.
53. Wang, D., Song, H., Evans, J.A., Lang, J.C., Schuller, D.E. & Weghorst, C.M. (1997) Mutation and downregulation of the transforming growth factor beta type ii receptor gene in primary squamous cell carcinomas of the head and neck. Carcinogenesis, 18, 2285.
54. Watanabe, M.A., Oda, J.M., Amarante, M.K. & Cesar Voltarelli, J. (2010) Regulatory t cells and breast cancer: implications for immunopathogenesis. Cancer and Metastasis Reviews, 29, 569.
55. Wei, Y.S., Xu, Q.Q., Wang, C.F., Pan, Y., Liang, F. & Long, X.K. (2007a) Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma. Tissue Antigens, 70, 464.
56. Wei, Y.S., Zhu, Y.H., Du, B., Yang, Z.H., Liang, W.B., Lv, M.L. et al. (2007b) Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma. Clinica Chimica Acta, 380, 165.
57. Wrzesinski, S.H., Wan, Y.Y. & Flavell, R.A. (2007) Transforming growth factor-beta and the immune response: implications for anticancer therapy. Clinical Cancer Research, 13, 5262.
58. Wu, G.Y., Hasenberg, T., Magdeburg, R., Bonninghoff, R., Sturm, J.W. & Keese, M. (2009) Association between egf, tgf-beta1, vegf gene polymorphism and colorectal cancer. World Journal of Surgery, 33, 124.
59. Yeudall, W.A. & Miyazaki, H. (2007) Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? Expert Review of Anticancer Therapy, 7, 351.
60. Yoshimura, A. & Muto, G. (2011) Tgf-beta function in immune suppression. Current Topics in Microbiology and Immunology, 350, 127.
61. Zhao, L., Sheldon, K., Chen, M., Yin, M.S., Hayman, J.A., Kalemkerian, G.P. et al. (2008) The predictive role of plasma tgf-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer. Lung Cancer, 59, 232.
62. Zheng, W. (2009) Genetic polymorphisms in the transforming growth factor-beta signaling pathways and breast cancer risk and survival. Methods in Molecular Biology, 472, 265.